LMP1- and LMP2-specific cytotoxic T lymphocytes

· Baylor College of Medicine

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LMP1- and LMP2-specific cytotoxic T lymphocytes, covering 2012-04-16 to 2017-02-07. Get the full timeline:

Most recent: Clinical Trial Update: LMP1- and LMP2-Specific CTLs to Patients With EBV-Positive NPC (NATELLA) [Phase 1]